Global Scale,
Specialized Expertise.
In today’s complex bio-pharma landscape, we combine specialized expertise, innovation, and trusted partnership with the global scale and resources of the Ajinomoto Group to drive meaningful progress in the development and manufacturing of complex and novel medicines.
Our CDMO Services
Find the support your program needs across small molecules, oligonucleotides, peptides, gene therapies, proteins, and bioconjugates.
Small Molecule Manufacturing
APIs and intermediates, including specialized solutions for complex chemistry.
Oligonucleotide Manufacturing
Solid-phase synthesis and proprietary AJIPHASE™ liquid-phase technology.
Protein Manufacturing
Recombinant protein production through secretion for simplified purification and higher purity.
Building on a Legacy of Scientific Innovation
For more than a century, Ajinomoto Group has pioneered science to solve complex challenges and create new possibilities for people, society, and the planet.
That legacy of scientific rigor, R&D excellence, and continuous innovation shapes how we approach biopharma development and manufacturing today, from advancing processes for increasingly complex medicines to creating proprietary technologies such as AJIPHASE™, AJICAP™, CORYNEX™ that give biopharma innovators new ways to advance their science.
Seven sites across four countries, connected as one global network
With businesses and manufacturing sites in Belgium, India, Japan, and the U.S., we combine deep modality expertise with Ajinomoto Group’s century-long legacy of scientific innovation and share a commitment to quality, operational excellence, and sustainability to help biopharma partners advance complex and novel medicines and improve the health of humankind.
